Date and time: 14 May 2026, 15:00–16:30 (BST)
Speakers: Dr. Joel Bercu(@jbercu)and Dr. Ben Thornton
What you will learn
- How the nitrosamine landscape is evolving and how guidance is shaping qualification strategies
- How to apply CPCA to support nitrosamine qualification in line with current recommendations
- How in silico tools, including (Q)SAR Derek Nexus and Sarah Nexus, and databases such as LCDB Plus and Vitic, support CPCA-based assessments
- Key considerations when assessing nitrosamine potency as part of qualification
- Insights from a real-world case study demonstrating nitrosamine qualification in practice
- Expert perspectives on current challenges and emerging best practices through a live panel discussion
I am looking forward to participating.